Literature DB >> 16230524

Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops.

Faisel Khan1, Jill J F Belch, Maureen MacLeod, Gary Mires.   

Abstract

Endothelial dysfunction is important in the pathophysiology of preeclampsia. No study has examined endothelial function sequentially at different gestations before development of the clinical syndrome and after delivery (to compare maternal from placental influences). We sought to determine whether endothelial function changes before the clinical development of preeclampsia. We measured skin microvascular function using iontophoresis of acetylcholine and sodium nitroprusside, and laser Doppler imaging at 22, 26, 34 weeks' gestation and 6 weeks postpartum in women identified as being at increased risk of preeclampsia, based on uterine artery Doppler waveforms at 18 to 20 weeks, and controls with normal Doppler waveforms. Fifty-four women remained normotensive and preeclampsia developed in 15. In normotensive and preeclamptic women, acetylcholine responses were augmented during pregnancy compared with postpartum responses (P<0.001). Sodium nitroprusside responses were augmented during pregnancy compared with those postpartum (P<0.005) in preeclamptic women only. Microvascular responses were augmented in women in whom preeclampsia developed, compared with those in normotensive women, at 26 and 34 weeks for acetylcholine (P<0.05 and P<0.001, respectively) and at 22 and 26 weeks for sodium nitroprusside (P<0.05 and P<0.02, respectively). Postpartum acetylcholine and sodium nitroprusside responses were not significantly different between preeclamptic and normal women. Microvascular responses are enhanced during pregnancy in women in whom preeclampsia develops to a level above that seen in normotensive women. These changes precede the onset of clinical disease and might be related to a compensatory increased sensitivity of the microcirculation to nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230524     DOI: 10.1161/01.HYP.0000186328.90667.95

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

Review 3.  Thermal provocation to evaluate microvascular reactivity in human skin.

Authors:  Christopher T Minson
Journal:  J Appl Physiol (1985)       Date:  2010-05-27

4.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 5.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 6.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

Review 7.  Preeclampsia: Syndrome or Disease?

Authors:  Leslie Myatt; James M Roberts
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

8.  Alteration of skin laser-Doppler flux response to local cooling in gestational hypertension.

Authors:  Ksenija Cankar; Nejka Potocnik; Martin Strucl
Journal:  Clin Auton Res       Date:  2010-01-09       Impact factor: 4.435

9.  Selective serotonin reuptake inhibitors and endothelial function in women.

Authors:  Liisa Hantsoo; Kathryn A Czarkowski; Josiah Child; Christopher Howes; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2014-06-02       Impact factor: 2.681

Review 10.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.